Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxinSIENA, S; VILLA, S; BREGNI, M et al.Blood. 1987, Vol 69, Num 1, pp 345-348, issn 0006-4971Article

MURINE MONOCLONAL ANTIBODY THERAPY IN TWO PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA = TRAITEMENT PAR DES ANTICORPS MONOCLONAUX MURINS DE DEUX MALADES ATTEINTS DE LEUCEMIE LYMPHOCYTAIRE CHRONIQUEDILLMAN RO; SHAWLER DL; SOBOL RE et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 5; PP. 1036-1045; BIBL. 26 REF.Article

T-Cell detection with monoclonal antibody T101 kitsPOLLACK, S. M; CIMINO, E. F; ROBBINS, D. S et al.Journal of clinical microbiology (Print). 1986, Vol 23, Num 5, pp 951-953, issn 0095-1137Article

T101 MONOCLONAL ANTIBODY THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIADILLMAN RO; SOBOL RE; COLLINS H et al.1982; PROG. CANCER RES. THER.; ISSN 0145-3726; USA; DA. 1982; VOL. 21; PP. 151-171; BIBL. 26 REF.Conference Paper

T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic aminesCASELLAS, P; RAVEL, S; BOURRIE, B. J. P et al.Blood. 1988, Vol 72, Num 4, pp 1197-1202, issn 0006-4971Article

A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxinsMARSH, J. W; NEVILLE, D. M. JR.The Journal of immunology (1950). 1988, Vol 140, Num 10, pp 3674-3678, issn 0022-1767Article

An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensinHERTLER, A. A; SCHLOSSMAN, D. M; BOROWITZ, M. J et al.International journal of cancer. 1989, Vol 43, Num 2, pp 215-219, issn 0020-7136Article

Determination of sensitivity of fresh leukemia cells to immunotoxinsLAURENT, G; KUHLEIN, E; CASELLAS, P et al.Cancer research (Baltimore). 1986, Vol 46, Num 5, pp 2289-2294, issn 0008-5472Article

Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins = Elimination de cellules leucémiques-T clonogènes de la moelle osseuse humaine à l'aide d'immunotoxines antiprotéines de masse moléculaire 65000STONG, R. C; YOULE, R. J; VALLERA, D. A et al.Cancer research (Baltimore). 1984, Vol 44, Num 7, pp 3000-3006, issn 0008-5472Article

Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patientsLAURENT, G; PRIS, J; FARCET, J.-P et al.Blood. 1986, Vol 67, Num 6, pp 1680-1687, issn 0006-4971Article

Immunolymphoscintigraphy and the dose dependence of ¹¹¹In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphomaKEENAN, A. M; WEINSTEIN, J. N; MULSHINE, J. L et al.Cancer research (Baltimore). 1987, Vol 47, Num 22, pp 6093-6099, issn 0008-5472Article

Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (cD5) ricin A-chain immunotoxinSIENA, S; VILLA, S; BONADONNA, G et al.Transplantation. 1987, Vol 43, Num 3, pp 421-426, issn 0041-1337Article

Human leukemia cell binding and killing by anti-CD5 radioimmunotoxinsBUCHSBAUM, D. J; NELSON, L. A; HANNA, D. E et al.International journal of radiation oncology, biology, physics. 1987, Vol 13, Num 11, pp 1701-1712, issn 0360-3016Conference Paper

Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse modelLEONARD, J. E; JOHNSON, D. E; SHAWLER, D. L et al.Cancer research (Baltimore). 1988, Vol 48, Num 17, pp 4862-4867, issn 0008-5472Article

Antigenic modulation by anti-CD5 immunotoxinsMANSKE, J. M; BUCHSBAUM, D. J; AZEMOVE, S. M et al.The Journal of immunology (1950). 1986, Vol 136, Num 12, pp 4721-4728, issn 0022-1767Article

Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlationBERTRAM, J. H; GILL, P. S; LEVINE, A. M et al.Blood. 1986, Vol 68, Num 3, pp 752-761, issn 0006-4971Article

Autogreffe de moelle osseuse traitée par l'immunotoxine T 101 pour le traitement des leucémies et lymphomes T: premières observations cliniques = Autologous bone marrow treated with immunotoxin T 101 transplantation for treatment of T cell leukemia and lymphoma. First clinical reportsGORIN, N. C; DOUAY, L; DUHAMEL, G et al.La Presse médicale (1983). 1985, Vol 14, Num 37, pp 1909-1912, issn 0755-4982Article

Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxinsDEROCQ, J.-M; CASELLAS, P; LAURENT, G et al.The Journal of immunology (1950). 1988, Vol 141, Num 8, pp 2837-2843, issn 0022-1767Article

Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibodyKEENAN, A. M; WEINSTEIN, J. N; MULSHINE, J. L et al.Journal of nuclear medicine. 1987, Vol 28, Num 1, pp 42-46, issn 0097-9058Article

Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapySHAWLER, D. L; BEAUREGARD, J; HALPERN, S. E et al.Clinical immunology and immunopathology (Print). 1986, Vol 41, Num 1, pp 43-54, issn 0090-1229Article

Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers)AL SAATI, T; LAURENT, G; CAVERIVIERE, P et al.Clinical and experimental immunology (Print). 1984, Vol 58, Num 3, pp 631-638, issn 0009-9104Article

Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphomaCARRASQUILLO, J. A; MULSHINE, J. L; LARSON, S. M et al.Journal of nuclear medicine. 1987, Vol 28, Num 3, pp 281-287, issn 0097-9058Article

Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapySCHROFF, R. W; FOON, K. A; BEATTY, S. M et al.Cancer research (Baltimore). 1985, Vol 45, Num 2, pp 879-885, issn 0008-5472Article

Enhancing effects of monocytes on modulation of a lymphocyte membrane antigenSCHROFF, R. W; KLEIN, R. A; FARRELL, M. M et al.The Journal of immunology (1950). 1984, Vol 133, Num 4, pp 2270-2277, issn 0022-1767Article

Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101SHAWLER, D. L; JOHNSON, D. E; MCCALLISTER, T. J et al.Clinical immunology and immunopathology (Print). 1988, Vol 47, Num 2, pp 219-229, issn 0090-1229Article